Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1PRETEXT I Hepatoblastoma 1Myeloproliferative Disorders 1Leukemia, Biphenotypic, Acute 1Ganglioneuroblastoma 1Burkitt Lymphoma 1Blast Crisis 1

Interventions

Cyclophosphamide 13Vincristine 10Etoposide 8Methotrexate 7Doxorubicin 7Dexamethasone 7Cytarabine 7venetoclax 6Calcium Dobesilate 6merphos 5dexamethasone acetate 5dexamethasone 21-phosphate 5calaspargase pegol 5auricularum 5Specimen Handling 5Prednisone 5prednylidene 4pegaspargase 4deltacortene 4Thioguanine 4Mercaptopurine 4Magnetic Resonance Spectroscopy 4Leucovorin 4Granulocyte Colony-Stimulating Factor 4Daunorubicin 4Asparaginase 4fludarabine phosphate 3daratumumab 3azathiopurine 3Rituximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Razoxane × 90 days × Clear all
NCT03007147 2026-05-04

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Active not recruiting
475 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡